• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Toshiba's Asteion CT scanner

Article

A new CT scanner from Toshiba America Medical Systems has received 510(k) clearance from the Food and Drug Administration. The system, called Asteion, is a subsecond scanner, and Toshiba has positioned it just below the Tustin, CA, vendor's new Aquilion

A new CT scanner from Toshiba America Medical Systems has received 510(k) clearance from the Food and Drug Administration. The system, called Asteion, is a subsecond scanner, and Toshiba has positioned it just below the Tustin, CA, vendor's new Aquilion half-second CT unit (SCAN 9/16/98). Toshiba will introduce Asteion at the upcoming Radiological Society of North America meeting.

Asteion features a 0.75-second rotation speed and solid-state detectors, according to Charles Corogenes, director of the CT business unit at TAMS. The system will carry a 4-million-heat-unit HeliCool x-ray tube and a 48-kW generator. It has a similar graphical user interface to the Aquilion scanner. It will also come standard with Aspire CI, Toshiba's CT fluoroscopy package. Asteion shipments will begin in January, Corogenes said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.